Naturopathic Board Pushes for Title Protection and Statutory Clarity as Critics Warn of Overreach

Dr. Dara Thompson, president of the California Board of Naturopathic Medicine, and Executive Officer Rebecca Mitchell urged the joint committees to support statutory clarifications and title protection that, they said, would help consumers distinguish licensed naturopathic doctors from unlicensed practitioners.

"Our mission is to ensure that consumers are safe from individuals who violate the Naturopathic Doctors Act," Thompson said, noting that most of the board's enforcement workload concerns unlicensed activity and citing a recent fatality in which an unlicensed practitioner was implicated.

Rebecca Mitchell told the committee that more than 70% of enforcement cases involve unlicensed individuals using medical‑sounding titles and that consumer confusion routinely leads to complaints and, in at least one case, serious harm. She said modern naturopathic medical education distinguishes licensed naturopathic doctors from unregulated practitioners and argued title protection would reduce harm.

Opponents from complementary health communities — including representatives of iridology and reflexology associations — warned that expanding the board's jurisdiction or oversight of unlicensed complementary practitioners would exceed the Alternative and Complementary Health Care Act and could abridge legally protected practice. The International Iridology Practitioners Association and reflexology groups asked legislators to reaffirm statutory boundaries and to prevent regulatory overreach.

The California Medical Association and other medical stakeholders raised concerns about specific board proposals that would expand scope (prescribing medications or vaccine administration without physician oversight) and urged caution.

Why it matters: The balance between protecting the public from unlicensed practice and preserving lawful alternative and complementary health practices is contested; changes to title protection or scope could affect both public safety and the regulatory reach of the board.

Next steps: Lawmakers asked clarifying questions and signaled further review; no final action was taken at the hearing.